6.41

2.14% -0.13

Health Catalyst Inc (HCAT)

Overview News Price History Option Chain Financials Discussions Forecast

Health Catalyst Inc stock is currently priced at $6.41, with a 24-hour trading volume of 239.52K. It has seen a -2.14% decreased in the last 24 hours and a -4.33% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $6.44 pivot point. If it approaches the $6.26 support level, significant changes may occur.

Previous Close:

$6.54

Open:

$6.67

24h Volume:

239.52K

Market Cap:

$381.35M

Revenue:

$295.94M

Net Income/Loss:

$-118.15M

P/E Ratio:

-2.3918

EPS:

-2.68

Net Cash Flow:

$-47.39M

1W Performance:

+6.14%

1M Performance:

-4.33%

6M Performance:

-15.79%

1Y Performance:

-49.04%

1D Range:

$6.36

$6.80

52W Range:

$5.445

$14.37

Health Catalyst Inc Stock (HCAT) Company Profile

Name

Health Catalyst Inc

Sector

Healthcare (1223)

Industry

Health Information Services (61)

Phone

855-309-6800

Address

3165 East Millrock Drive, Suite 400, Salt Lake City

Employee

728

Twitter

@HealthCatalyst

Next Earnings Date

2024-05-09

Latest SEC Filings

HCAT's Discussions on Twitter

Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-10-23	Downgrade	Guggenheim	Buy → Neutral
May-10-23	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-20-23	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Apr-12-23	Initiated	Stephens	Equal-Weight
Apr-04-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line
Oct-31-22	Initiated	Wells Fargo	Equal Weight
Oct-25-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-13-22	Downgrade	Piper Sandler	Overweight → Neutral
Aug-05-22	Downgrade	JP Morgan	Overweight → Neutral
Aug-05-22	Downgrade	Stifel	Buy → Hold
Apr-14-22	Initiated	Guggenheim	Buy
Mar-17-22	Upgrade	Jefferies	Hold → Buy
Feb-11-22	Initiated	Goldman	Buy
Dec-02-21	Initiated	Jefferies	Hold
Oct-14-21	Initiated	BTIG Research	Buy
Apr-29-21	Resumed	JP Morgan	Overweight
Dec-08-20	Initiated	Berenberg	Buy
Jul-14-20	Initiated	Citigroup	Buy
Jun-18-20	Initiated	Stifel	Buy
Jun-15-20	Resumed	Evercore ISI	Outperform
May-15-20	Initiated	Guggenheim	Buy
Apr-21-20	Initiated	RBC Capital Mkts	Outperform
Apr-13-20	Initiated	SVB Leerink	Outperform
Apr-02-20	Initiated	Canaccord Genuity	Buy
Dec-20-19	Initiated	Raymond James	Strong Buy
Oct-30-19	Initiated	Cantor Fitzgerald	Overweight
Aug-19-19	Initiated	Evercore ISI	Outperform
Aug-19-19	Initiated	Goldman	Buy
Aug-19-19	Initiated	JP Morgan	Overweight
Aug-19-19	Initiated	Piper Jaffray	Overweight
Aug-19-19	Initiated	SVB Leerink	Outperform
Aug-19-19	Initiated	SunTrust	Buy
Aug-19-19	Initiated	William Blair	Outperform

View All

Health Catalyst Inc Stock (HCAT) Latest News

SMART Global Reports Q2 Results, Joins Health Catalyst And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga

Brookdale Senior (BKD) Sees Y/Y Increase in Q1 Occupancy Levels

Zacks Investment Research

Health Catalyst Inc Stock (HCAT) Financials Data

Health Catalyst Inc (HCAT) Revenue 2024

HCAT reported a revenue (TTM) of $295.94 million for the quarter ending December 31, 2023, a +7.13% rise year-over-year.

Health Catalyst Inc (HCAT) Net Income 2024

HCAT net income (TTM) was -$118.15 million for the quarter ending December 31, 2023, a +14.01% increase year-over-year.

Health Catalyst Inc (HCAT) Cash Flow 2024

HCAT recorded a free cash flow (TTM) of -$47.39 million for the quarter ending December 31, 2023, a +10.05% increase year-over-year.

Health Catalyst Inc (HCAT) Earnings per Share 2024

HCAT earnings per share (TTM) was -$2.10 for the quarter ending December 31, 2023, a +21.05% growth year-over-year.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. The company is headquartered in Salt Lake City, Utah.